Edition:
United States

People: Abbott Laboratories (ABT)

ABT on New York Consolidated

38.10USD
4 May 2016
Change (% chg)

$-0.45 (-1.17%)
Prev Close
$38.55
Open
$38.35
Day's High
$38.46
Day's Low
$38.00
Volume
13,975,308
Avg. Vol
8,015,793
52-wk High
$51.74
52-wk Low
$36.00

Search Stocks

Summary

Name Age Since Current Position

Miles White

61 1999 Chairman of the Board, Chief Executive Officer

Brian Yoor

46 2015 Chief Financial Officer, Senior Vice President - Finance

Thomas Freyman

61 2015 Executive Vice President - Finance and Administration

Hubert Allen

50 2013 Executive Vice President, General Counsel, Secretary

Stephen Fussell

58 2013 Executive Vice President - Human Resources

Richard Ashley

72 2004 Executive Vice President - Corporate Development

Brian Blaser

51 2012 Executive Vice President - Diagnostics Products

John Capek

54 2015 Executive Vice President - Ventures

Robert Ford

42 2015 Executive Vice President - Medical Devices

Heather Mason

55 2015 Executive Vice President - Nutritional Products

Michael Warmuth

53 2012 Executive Vice President - Established Pharmaceuticals

Roger Bird

59 2015 Senior Vice President - U.S. Nutrition

Jaime Contreras

59 2013 Senior Vice President - Core Laboratory Diagnostics, Commercial Operations

Thomas Frinzi

60 2016 Senior Vice President - Abbott Medical Optics

Andrew Lane

45 2015 Senior Vice President - Established Pharmaceuticals, Emerging Markets

Deepak Nath

43 2015 Senior Vice President - Abbott Vascular

Jean-Yves Pavee

52 2015 Senior Vice President - Established Pharmaceuticals, Commercial Strategy

Daniel Salvadori

37 2014 Senior Vice President, Established Pharmaceuticals, Latin America.

Jared Watkin

48 2015 Senior Vice President - Diabetes Care

Robert Funck

54 2013 Vice President, Controller

Robert Alpern

65 2008 Independent Director

Roxanne Austin

55 2000 Independent Director

Sally Blount

54 2011 Independent Director

W. James Farrell

73 2006 Independent Director

Edward Liddy

70 2010 Independent Director

Nancy McKinstry

57 2011 Independent Director

Phebe Novakovic

58 2010 Independent Director

William Osborn

68 2008 Independent Director

Samuel Scott

71 2007 Independent Director

Glenn Tilton

67 2007 Independent Director

Biographies

Name Description

Miles White

Mr. Miles D. White is Chairman of the Board, Chief Executive Officer of the Company. He served as an Executive Vice President of Abbott from 1998 to 1999. He joined Abbott in 1984. He currently serves as a Director of Caterpillar Inc. and McDonald's Corporation. Serving as Abbott's Chairman of the Board and Chief Executive Officer since 1999 and having joined Abbott in 1984, Mr. White contributes not only his valuable business, management and leadership experience, but also his extensive knowledge of the Company and its global operations, as well as key insights into strategic, management and operation matters, ensuring the appropriate level of oversight and responsibility is applied to all Board decisions.

Brian Yoor

Mr. Brian B. Yoor has been appointed as Chief Financial Officer, Senior Vice President - Finance of the Company, effective June 1, 2015. He has served as the Company’s Vice President, Investor Relations since 2013, and as Divisional Vice President, Controller Diagnostic Products from 2010 to 2013. Mr. Yoor became a corporate officer in 2013. He joined the Company in 1997.

Thomas Freyman

Mr. Thomas C. Freyman is Executive Vice President - Finance and Administration of the Company. He was appointed to his current role in February 2004 and has served as Abbott's Chief Financial Officer since 2001. Mr. Freyman joined Abbott in 1979, and has served in a number of financial planning and analysis positions. In 1984, Mr. Freyman was appointed Finance Director for Abbott's European distribution center in the Netherlands. He also served as Division Controller, Corporate Materials Management, Vice President and Treasurer, and Vice President and Controller, Hospital Products Division. Prior to joining Abbott, Mr. Freyman was a Certified Public Accountant with Ernst & Whinney, Chicago. Mr. Freyman serves on the board of directors for the Chicago Botanic Garden. He is also a member of the Economic Club of Chicago, the Executives' Club of Chicago, the Healthcare Leadership Council and the S&P Corporate Ratings Issuer Council. He earned a Bachelor's degree in Accounting from the University of Illinois and a Master's degree in Management from Northwestern University.

Hubert Allen

Mr. Hubert L. Allen is Executive Vice President, General Counsel and Secretary of the Company. From 2010 to 2012 — Divisional Vice President and Associate General Counsel, Established Pharmaceuticals; 2009 to 2010 — Divisional Vice President and Associate General Counsel, Proprietary Pharmaceuticals; 2007 to 2009 — Section Head, Legal, Abbott Nutrition.

Stephen Fussell

Mr. Stephen R. Fussell is Executive Vice President - Human Resources of Abbott Laboratories. Previously, he served as Vice President, Compensation and Development. He joined Abbott in 1996, as Divisional Vice President, Compensation and Benefits. Prior to joining Abbott, Mr. Fussell was Vice President, Total Compensation and Workforce Information at Nestlé USA. Mr. Fussell is a board member for the Clara Abbott Foundation and the Abbott Fund. He earned a Bachelor's degree in Management and Administration from Louisiana State University in Baton Rouge.

Richard Ashley

Mr. Richard W. Ashley is Executive Vice President - Corporate Development of the Company. His responsibilities include various aspects of corporate strategic planning and business development. Ashley was appointed to his current position in February of 2004. Prior to joining Abbott, he was a Senior Director at McKinsey and Company, a former Managing Partner of the firm's Chicago office, and Head of the firm's Global Leadership and Organization practice. During his 31 years with McKinsey, Ashley consulted with clients in healthcare, energy and industrial manufacturing industries across a wide range of business and organizational issues. Mr. Ashley is a member of the Executive Committee of the board of directors of Junior Achievement of Chicago and a former member of the Civic Committee of the Commercial Club of Chicago. He is also a member of the American Bar Association and the Wisconsin Bar Association. He earned a Bachelor's Degree in Political Science and Master's degree in Business Administration from Northwestern University. He also holds a Juris Doctorate from the University of Wisconsin Law School.

Brian Blaser

Mr. Brian J. Blaser is Executive Vice President - Diagnostics Products of the Company. He was appointed to his current position in June 2010. Previously, Mr. Blaser served as Vice President, Diagnostics Operations; Divisional Vice President, Global Operations; and Divisional Vice President, Reagent Manufacturing, all for Abbott Diagnostics. Prior to joining Abbott, Mr. Blaser held several positions of increasing responsibility in engineering, finance and operations at Johnson & Johnson, Eastman Kodak and General Motors. He earned a bachelor's degree in mechanical engineering technology from the University of Dayton and a master's degree in business administration from Rochester Institute of Technology.

John Capek

Dr. John M. Capek, Ph.D. is Executive Vice President - Ventures of the Company, effective June 1, 2015. Previously, he served as Senior Vice President, Abbott Vascular, heading up Abbott's global vascular business. Dr. Capek served in various management roles at Guidant, including president, Guidant Vascular Intervention and Vice President and General Manager of Bioabsorbable Vascular Solutions. He also served as Vice President and General Manager of Guidant Germany and Vice President, Marketing, Guidant Cardiac Rhythm Management Group. Before joining Guidant, Dr. Capek was manager of New Product Technology at Eli Lilly & Company. Dr. Capek has a Bachelor's degree in Biomedical Engineering, a Master's degree in Biomedical Engineering, a Master's degree in Electrical Engineering, a Ph.D. in Biomedical Engineering and a Master's degree in Business Administration from Rensselaer Polytechnic Institute.

Robert Ford

Mr. Robert Ford is Executive Vice President - Medical Devices of the Company since 2015. He served as Senior Vice President, Diabetes Care of the Company between 2014 and 2015. From 2008 to 2014 — Vice President, Diabetes Care, Commercial Operations. He was elected Corporate Officer — 2008.

Heather Mason

Ms. Heather L. Mason is Executive Vice President - Nutritional Products of the Company. She served as Executive Vice President - Nutritional Products, Global Commercial Operations.of the company fro 2014-2015. Ms. Mason previously served as Vice President, Latin American Operations in Abbott's international pharmaceutical business. Ms. Mason joined Abbott in 1990. She held a number of positions in Abbott's U.S. pharmaceutical business, including oversight of Abbott's specialty pharmaceuticals, the diabetes/metabolics and oncology franchises, and managed health care. Ms. Mason also served as Vice President, International Marketing in Abbott's international pharmaceutical business. Prior to joining Abbott, Ms. Mason worked for Quaker Oats and FMC Corporation. Ms. Mason is an advisory board member of the Healthcare Businesswomen’s Association and Corporate Advisor for the Juvenile Diabetes Research Foundation and American Diabetes Association. She earned a Bachelor's degree in Engineering from the University of Michigan and a Master's degree in Business Administration from the University of Chicago.

Michael Warmuth

Mr. Michael J. Warmuth is Executive Vice President - Established Pharmaceuticals of Abbott Laboratories, since November 2012. Most recently, Mr. Warmuth served as Senior Vice President, Established Pharmaceuticals, which previously operated as part of Abbott’s global pharmaceutical business. Mr. Warmuth joined Abbott in 1986 as part of Abbott's manufacturing professional development program. He served in a variety of management roles including Senior Vice President, Diagnostics, heading Abbott’s global core laboratory Diagnostics business; Vice President and General Manager, Hematology, in Abbott's Diagnostics business; Vice President, Global Engineering Services; Divisional Vice President of Pharmaceutical Operations; and Divisional Vice President of Corporate Quality Operations. He earned a bachelor's degree in business administration from the University of Wisconsin-Whitewater and a master's degree in business administration from Northwestern University.

Roger Bird

Mr. Roger Bird is Senior Vice President, U.S. Nutrition of the Company. Between 2009 to 2015 he is Divisional Vice President and General Manager, China and Hong Kong, Nutritional Products. He is Elected Corporate Officer 2015.

Jaime Contreras

Mr. Jaime Contreras is the Senior Vice President - Core Laboratory Diagnostics, Commercial Operations of Abbott Laboratories. From 2008 to 2013 he was Vice President, Diagnostics, Global Commercial Operations. He was elected as Corporate Officer in 2003.

Thomas Frinzi

Mr. Thomas G. Frinzi is Senior Vice President - Abbott Medical Optics of the Company. From 2010 to 2015 he is President and Chief Executive Officer, WaveTec Vision Systems, Inc. (a leading U.S. developer of guidance technology for cataract surgery). He is Elected as Corporate Officer in 2016.

Andrew Lane

Mr. Andrew H. Lane is Senior Vice President - Established Pharmaceuticals, Emerging Markets of the Company since 2015. Between 2014 to 2015 served with Divisional Vice President, Established Pharmaceuticals, Asia Pacific. Between 2011 to 2014 Lane is Vice President, Asia Pacific, Takeda Pharmaceutical Company Limited (a Japanese pharmaceutical company). Elected as Corporate Officer in 2015.

Deepak Nath

Mr. Deepak S. Nath is Senior Vice President, Abbott Vascular of the Company. Currently he is Vice President, Vascular, Commercial. Between 2014 to 2015 he is Vice President, Molecular Diagnostics. Between 2012 to 2014 he is Divisional Vice President and General Manager, Ibis. Between 2011 to 2012 he is Divisional Vice President, CEEMEA, Vascular. Between 2009 to 2011 he is Divisional Vice President and General Manager, Nordics and Eastern European Operations, Vascular. He was Elected Corporate Officer — 2014.

Jean-Yves Pavee

Mr. Jean-Yves F. Pavee is Senior Vice President - Established Pharmaceuticals, Commercial Strategy of the Company. From 2011 to 2013 — Divisional Vice President, Established Pharmaceuticals, EMEA East. From 2008 to 2011 — Divisional Vice President, Europe South. He was elected Corporate Officer — 2013.

Daniel Salvadori

Mr. Daniel Salvadori is the Senior Vice President, Established Pharmaceuticals, Latin America of the Company. From 2013 to 2014 — Chief Executive Officer, Latin America, CFR Pharmaceuticals S.A. (a Latin American pharmaceutical company). From 2012 to 2013 — Executive President, Complex Therapeutics Division, CFR Pharmaceuticals S.A. From 2010 to 2012 — Head of Sales and Marketing, Latin America, Sandoz Pharmaceuticals, Novartis AG (a Swiss multinational pharmaceutical company). From 2009 to 2010 — Director of Global Strategy and Mergers and Acquisitions, Sandoz Pharmaceuticals, Novartis AG. He was elected Corporate Officer — 2014.

Jared Watkin

Mr. Jared L. Watkin is Senior Vice President, Diabetes Care of the Company. Between 2010 to 2015 Divisional Vice President, Technical Operations, Diabetes Care. Elected as Corporate Officer in 2015.

Robert Funck

Mr. Robert E. Funck is Vice President, Controller of Abbott Laboratories. Mr. Funck has served as the Company’s Vice President, Chief Ethics and Compliance Officer since 2009, as Vice President, Internal Audit from 2007 to 2009, and as Vice President and Treasurer from 2005 to 2007. Mr. Funck became a corporate officer in 2005. Mr. Funck joined the Company in 1987.

Robert Alpern

Dr. Robert J. Alpern, M.D. is Independent Director of the Company. Dr. Alpern has served as the Ensign Professor of Medicine, Professor of Internal Medicine, and Dean of Yale School of Medicine since June 2004. From July 1998 to June 2004, Dr. Alpern was the Dean of The University of Texas Southwestern Medical Center. Dr. Alpern also serves as a Director of AbbVie Inc. and as a Director on the Board of Yale—New Haven Hospital. As the Ensign Professor of Medicine, Professor of Internal Medicine, and Dean of Yale School of Medicine, Dean of The University of Texas Southwestern Medical Center, and as a Director on the Board of Yale—New Haven Hospital, Dr. Alpern contributes valuable insights to the Board through his medical and scientific expertise and his knowledge of the health care environment and the scientific nature of Abbott's key research and development initiatives.

Roxanne Austin

Ms. Roxanne S. Austin is Independent Director of the Company. Ms. Austin is President of Austin Investment Advisors, a private investment and consulting firm, a position she has held since 2004. From July 2009 through July 2010, Ms. Austin also served as the President and Chief Executive Officer of Move Networks, Inc., a provider of Internet television services. Ms. Austin served as President and Chief Operating Officer of DIRECTV, Inc. Ms. Austin also previously served as Executive Vice President and Chief Financial Officer of Hughes Electronics Corporation and as a partner of Deloitte & Touche LLP. Ms. Austin is also a Director of AbbVie Inc., Target Corporation, Teledyne Technologies, Inc., and Telefonaktiebolaget LM Ericsson. Through her extensive management and operating roles, including her financial roles, Ms. Austin contributes significant oversight and leadership experience, including financial expertise and knowledge of financial statements, corporate finance and accounting matters.

Sally Blount

Ms. Sally E. Blount, Ph.D. is Independent Director of the Company. Ms. Blount has served as Dean of the J.L. Kellogg Graduate School of Management at Northwestern University since July 2010. From 2004 to 2010, she served as the Vice Dean and Dean of the undergraduate college of New York University's Leonard N. Stern School of Business. Ms. Blount joined the faculty of New York University's Leonard N. Stern School of Business in 2001 and was the Abraham L. Gitlow Professor of Management and Organizations. Prior to joining NYU in 2001, Ms. Blount held academic posts at the University of Chicago's Graduate School of Business from 1992 to 2001. As Dean of the J.L. Kellogg Graduate School of Management at Northwestern University and as the Vice Dean and Dean of the undergraduate college of New York University's Leonard N. Stern School of Business, Ms. Blount provides Abbott's Board with expertise on business organization, governance and business management matters.

W. James Farrell

Mr. W. James Farrell is Independent Director of the Company. Mr. Farrell served as the Chairman of Illinois Tool Works Inc. from 1996 to 2006 and as its Chief Executive Officer from 1995 to 2005. Mr. Farrell also served on the Board of Directors of 3M Company from 2006 to 2014, Allstate Insurance Company from 1999 to 2013, and UAL Corporation from 2001 to 2012. As a result of his tenure as Chairman and Chief Executive Officer of Illinois Tool Works, Mr. Farrell brings valuable business, leadership and management experience to the Board and provides guidance on key matters relevant to a major international company.

Edward Liddy

Mr. Edward M. Liddy is Independent Director of the Company. Mr. Liddy served as a partner in the private equity investment firm Clayton, Dubilier & Rice, LLC from January 2010 to December 2015. At the request of the Secretary of the U.S. Department of Treasury, Mr. Liddy served as Interim Chairman and Chief Executive Officer of American International Group, Inc., a global insurance and financial services holding company, from September 2008 until August 2009. From January 1999 to April 2008, Mr. Liddy served as Chairman of the Board of the Allstate Corporation. He served as Chief Executive Officer of Allstate from January 1999 to December 2006, President from January 1995 to May 2005, and Chief Operating Officer from August 1994 to January 1999. Mr. Liddy currently serves on the Board of Directors of AbbVie Inc., 3M Company, and The Boeing Company. Through his executive leadership at Allstate and American International Group, and his board service at several Fortune 100 companies across a broad range of industries, Mr. Liddy provides valuable insights on corporate strategy, risk management, corporate governance and many other issues facing large, global enterprises. Additionally, as a former chief financial officer, audit committee chair at Goldman Sachs and 3M Company, and partner at Clayton, Dubilier & Rice, LLC, Mr. Liddy provides significant knowledge and understanding of corporate finance, capital markets, financial reporting and accounting matters.

Nancy McKinstry

Ms. Nancy McKinstry is Independent Director of the Company. Ms. McKinstry has been the Chief Executive Officer and Chairman of the Executive Board of Wolters Kluwer N.V. since September 2003 and a member of its Executive Board since June 2001. Ms. McKinstry also serves on the Advisory Board of the University of Rhode Island, the Board of Overseers of Columbia Business School, and the Advisory Board of the Harrington School of Communication and Media. Ms. McKinstry served on the Board of Directors of Telefonieaktiebolaget LM Ericsson (LM Ericsson Telephone Company) from 2004 to 2012. Ms. McKinstry also served on the Board of Directors of MortgageIT Holdings, Inc. from 2004 to 2007. As the Chief Executive Officer and Chairman of the Executive Board of Wolters Kluwer N.V., Ms. McKinstry contributes global perspectives and management experience, including an understanding of key issues facing a multinational business such as Abbott's.

Phebe Novakovic

Ms. Phebe N. Novakovic is Independent Director of the Company. Ms. Novakovic has been Chairman and Chief Executive Officer of General Dynamics Corporation since January 1, 2013. Previously, she served as President and Chief Operating Officer from May 2012 to December 2012 and as Executive Vice President, Marine Systems of General Dynamics from May 2010 to May 2012. From May 2005 to April 2010, Ms. Novakovic served as its Senior Vice President—Planning and Development. She was elected Vice President of General Dynamics in October 2002 after joining the company in May 2001. Previously, Ms. Novakovic was Special Assistant to the Secretary and Deputy Secretary of Defense, and had been a Deputy Associate Director of the Office of Management and Budget. As a member of the Board of Directors and Chief Executive Officer of General Dynamics Corporation, Ms. Novakovic has strong management experience with a major public company, including significant marketing, operational and manufacturing experience, and contributes valuable insights into finance and capital markets. Her tenure with the Office of Management and Budget and as Special Assistant to the Secretary and Deputy Secretary of Defense enables her to provide government perspective and experience in a highly regulated industry.

William Osborn

Mr. William A. Osborn is Independent Director of the Company. Mr. Osborn was Chairman of Northern Trust Corporation from 1995 through 2009 and served as its Chief Executive Officer from 1995 through 2007. Mr. Osborn currently serves as a Director of Caterpillar Inc. and General Dynamics Corporation. He is Chairman of the Board of Trustees of Northwestern University. Mr. Osborn served on the Board of Directors of Nicor, Inc. from 1999 to 2006 and on the Board of Directors of Tribune Company from 2001 to 2012. As the Chairman and Chief Executive Officer of Northern Trust Corporation and The Northern Trust Company, Mr. Osborn acquired broad experience in successfully overseeing complex global businesses operating in highly regulated industries.

Samuel Scott

Mr. Samuel C. Scott, III., is Independent Director of the Company. Mr. Scott retired as Chairman, President and Chief Executive Officer of Corn Products International in 2009. He served as Chairman, President, and Chief Executive Officer from February 2001 until he retired in May of 2009. He was President and Chief Operating Officer from January 1998 until February 2001. He was President of the Corn Refining Division of CPC International from 1995 through 1997, when CPC International spun off Corn Products International as a separate corporation. Mr. Scott currently serves on the Board of Directors of Bank of New York Mellon Corporation and Motorola Solutions, Inc. As the Chairman, President and Chief Executive Officer of Corn Products International, Mr. Scott acquired valuable business, leadership and management experience, including critical insights into matters relevant to a major public company and experience in finance and capital markets matters.

Glenn Tilton

Mr. Glenn F. Tilton is Independent Director of the Company. Mr. Tilton served as Chairman of the Midwest for JPMorgan Chase & Co. and a member of its companywide Executive Committee from June 2011 to June 2014. From October 2010 to December 2012, Mr. Tilton also served as the Non-Executive Chairman of the Board of United Continental Holdings, Inc. From September 2002 to October 2010, he served as Chairman, President and Chief Executive Officer of UAL Corporation, a holding company, and Chairman and Chief Executive Officer of United Air Lines, Inc., an air transportation company and wholly owned subsidiary of UAL Corporation. Mr. Tilton is also a Director of AbbVie Inc. and Phillips 66. Mr. Tilton also served on the Board of Directors of Lincoln National Corporation from 2002 to 2007, of TXU Corporation from 2005 to 2007, of Corning Incorporated from 2010 to 2012, and of United Continental Holdings, Inc. from 2001 to 2013. Having previously served as Chairman of the Midwest for JPMorgan Chase & Co., Non-Executive Chairman of the Board of United Continental Holdings, Inc., Chairman, President, and Chief Executive Officer of UAL Corporation and United Air Lines, Vice Chairman of Chevron Texaco, and as Interim Chairman of Dynegy, Inc., Mr. Tilton acquired strong management experience overseeing complex multinational businesses operating in highly regulated industries, as well as expertise in finance and capital markets matters.
Search Stocks